What are the basic assessment, imaging, analgesia, reduction techniques, and post‑reduction management for acute joint dislocations?

Management of Acute Joint Dislocations

Initial Assessment

Verify neurovascular status immediately and document the extensor mechanism integrity before any intervention. 1

Critical Clinical Examination Points

• Neurovascular assessment: Check distal pulses, capillary refill, sensation, and motor function in the affected extremity 1
• Extensor mechanism testing: Patient must demonstrate active extension against gravity with no extension lag (particularly for patellar injuries) 1
• Fracture displacement: Measure any step-off or gap; fragments >2-3mm displacement require different management 1
• Compartment syndrome screening: Assess for pain out of proportion, tense compartments, or vascular compromise 1

Imaging Protocol

Standard Radiographic Views

• Shoulder dislocations: Obtain Zanca view (highly sensitive for Rockwood type V AC joint injuries), axillary view (100% sensitive for type IV and VI AC dislocations), and Alexander view (sensitive for type III and V) 2
• Hip dislocations: Standard AP pelvis and lateral views are essential; over 90% can be successfully reduced in the ED 3
• Serial imaging: Repeat radiographs at 1-2 week intervals for the first 3-4 weeks to monitor for late displacement 1

Advanced Imaging Considerations

• MRI accuracy: 97% accuracy with 96% sensitivity and 98% specificity for AC joint injuries 2
• Ultrasound: 95% accuracy with 96% sensitivity and 93% specificity, offering a cost-effective alternative 2
• CT scanning: 81% accuracy; less sensitive than MRI or ultrasound for soft tissue assessment 2

Analgesia Options

Intra-Articular Lidocaine (IAL)

For anterior shoulder dislocations, intra-articular lidocaine provides equivalent pain relief to IV sedation with significantly fewer adverse events and shorter ED length of stay. 4

• Success rate: 78.7% overall success (83% in males, 66.7% in females) without sedation 5
• Adverse events: Significantly lower than IV sedation (RR 0.16; 95% CI 0.07-0.33) 4
• ED length of stay: Reduced by approximately 1.48 hours compared to IV sedation 4
• Cost effectiveness: 32% less expensive than IV sedation 6
• Failure management: 19% failure rate requiring conversion to IV sedation 6

Intravenous Sedation

• Propofol: Lowest rate of respiratory depression compared to methohexital, fentanyl/midazolam, and etomidate 7
• Etomidate: 90% procedural success rate with minimal hypotension or arrhythmia risk; 8% desaturation rate 7
• Combination therapy caution: When using benzodiazepines with opioids, administer the opioid first (greater respiratory depression risk) and titrate the benzodiazepine carefully 7
• High-dose opioid risk: Avoid rapid administration; fentanyl >10 mg/kg over 4 minutes has caused respiratory arrest 7

Procedural Sedation Monitoring

• Respiratory monitoring: Approximately 50% of patients receiving propofol or methohexital meet criteria for subclinical respiratory depression on ETCO2 monitoring, though significant clinical complications are rare 7
• Bag-mask ventilation readiness: Brief apnea requiring assisted ventilation occurs in <5% of cases with etomidate 7

Reduction Techniques

Shoulder Dislocations

The external rotation method without sedation (ERWOSA) should be the first-line approach in busy EDs, particularly for male patients, if applied slowly to overcome muscle resistance. 5

• ERWOSA technique: Apply slow, gentle external rotation to avoid increasing muscle resistance; 78.7% success rate without analgesia 5
• Time advantage: ERWOSA reduces ED stay to 55±17 minutes versus 118±23 minutes with sedation 5
• Alternative approach: If ERWOSA fails, proceed to IAL (additional 19% success) or IV sedation 4, 6

Hip Dislocations

• Urgency: Require immediate reduction to minimize avascular necrosis risk 3
• Success rates: Individual reduction techniques range from 60-90% success 3
• Multiple technique familiarity: Emergency physicians should know several methods as initial attempts may fail or patient characteristics may limit certain maneuvers 3

Post-Reduction Management

Immobilization Protocol

• Shoulder: Apply appropriate sling or immobilizer based on dislocation type 2
• Knee/patella: Full extension knee immobilizer worn continuously except for hygiene and skin checks 1

Weight-Bearing Restrictions

• Initial status: Non-weight bearing or touch-down weight bearing with crutches 1
• Assistive devices: Provide crutches or walker to reduce affected limb loading 1

Follow-Up Timeline

• First visit: 5-7 days post-reduction to reassess extensor mechanism and check for displacement progression 1
• Serial monitoring: Radiographs every 1-2 weeks for 3-4 weeks to detect late displacement 1

Thromboprophylaxis

Consider pharmacologic VTE prophylaxis with LMWH for lower extremity immobilization, particularly when risk factors are present. 1

Special Population Considerations

Patients with Neuropathy

• Clinical decision rule limitations: Ottawa/Pittsburgh rules do not apply to patients with diabetes, paraplegia, or altered mental status 1
• Liberal imaging: These patients require radiographs regardless of clinical findings 1

Busy Emergency Departments

• Male patients: Particularly suitable candidates for ERWOSA approach, avoiding sedation complications and reducing throughput time 5
• Resource allocation: IAL and ERWOSA methods free up monitoring resources and reduce adverse event management 4, 5